Type IIA topoisomerase inhibition by a new class of antibacterial agents
GlaxoSmithKline (United Kingdom) · Molecular Discovery (United Kingdom) · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
832
total citations
- FWCI
- 17.01
- Percentile
- 100%
- References
- 52
Citations per year
Authors
25- BBB.D. BaxCorresponding
GlaxoSmithKline (United Kingdom), Molecular Discovery (United Kingdom)
- PFPan F. Chan
GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States)
- DSDrake S. Eggleston
MRC Laboratory of Molecular Biology, GlaxoSmithKline (United Kingdom)
- AFAndrew Fosberry
GlaxoSmithKline (United Kingdom)
- DRDaniel R. Gentry
GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States)
Topics & keywords
Topics
Keywords
- DNA gyrase
- Topoisomerase
- Topoisomerase IV
- DNA
- Mechanism of action
- Chemistry
- Drug discovery
- Active site
No related works found for this paper.